의약품 포장 시장 분석 및 예측 : 유형별, 제품 유형별, 재질별, 기술별, 용도별, 구성 요소별, 최종 사용자별, 기능별, 프로세스별, 솔루션별(-2035년)

Pharmaceutical Packaging Market is anticipated to expand from $117.2 billion in 2024 to $207.5 billion by 2034, growing at a CAGR of approximately 5.9%. The Pharmaceutical Packaging Market encompasses solutions designed to protect and preserve pharmaceutical products, ensuring their safety and efficacy. This market includes primary, secondary, and tertiary packaging, using materials such as glass, plastic, paper, and metal. Key drivers include increased drug production, stringent regulatory requirements, and the rise of biologics. Innovations in sustainable materials and smart packaging are shaping the market, catering to the demand for eco-friendly and patient-centric solutions.

The Pharmaceutical Packaging Market is experiencing robust growth, driven by innovation in packaging materials and sustainability trends. The primary packaging segment leads in performance, with blister packs and bottles being pivotal due to their protective qualities and convenience. Blister packs are favored for their dosage accuracy and tamper evidence, making them indispensable in the pharmaceutical supply chain. Following closely, the secondary packaging segment shows impressive growth, particularly with cartons and boxes, which enhance branding and provide additional protection. The demand for eco-friendly and biodegradable packaging solutions is increasing, reflecting the industry's shift towards sustainability. This trend is particularly evident in the rise of biodegradable films and recyclable materials. Moreover, smart packaging solutions, such as those incorporating RFID technology, are gaining prominence due to their ability to enhance supply chain efficiency and ensure product integrity. These advancements underscore the market's dynamic nature and its responsiveness to evolving consumer and regulatory demands.

The pharmaceutical packaging market is characterized by a diverse array of product offerings, with significant emphasis on innovation and sustainability. Market share is influenced by the introduction of eco-friendly packaging solutions and advanced technologies. Pricing strategies are increasingly competitive, with companies striving to balance cost-effectiveness with quality and compliance. New product launches focus on enhancing drug safety and extending shelf life, reflecting a shift towards more sophisticated packaging solutions. Competition benchmarking reveals a dynamic landscape, with leading firms continually investing in R&D to maintain a competitive edge. Regulatory influences play a critical role, with stringent guidelines shaping packaging standards globally. The market is witnessing robust growth in regions with strong regulatory frameworks, such as North America and Europe. Emerging markets in Asia-Pacific are also gaining traction, driven by increasing healthcare investments. The interplay of regulatory standards and technological advancements is pivotal, offering both challenges and opportunities for market participants.

Geographical Overview:

The pharmaceutical packaging market is witnessing notable growth across various regions, each presenting unique opportunities. North America remains at the forefront, driven by advanced healthcare infrastructure and stringent regulatory standards. The region's focus on sustainable packaging solutions further propels market expansion. In Europe, the market is bolstered by increasing demand for innovative packaging technologies, coupled with a strong emphasis on environmental sustainability. The Asia Pacific region is experiencing rapid growth, fueled by rising healthcare expenditure and expanding pharmaceutical manufacturing. Emerging economies such as India and China are pivotal to this growth, with their robust pharmaceutical industries and increasing investment in packaging technologies. Latin America and the Middle East & Africa are emerging as potential growth pockets. In Latin America, the market is supported by a growing pharmaceutical sector and increasing demand for modern packaging solutions. Meanwhile, the Middle East & Africa are witnessing increased investment in healthcare infrastructure, enhancing the region's market prospects.

Global tariffs and geopolitical tensions are significantly influencing the Pharmaceutical Packaging Market. In Japan and South Korea, firms are navigating increased tariffs by enhancing local production capabilities and investing in sustainable packaging innovations. China's strategy focuses on boosting domestic manufacturing resilience amidst export restrictions, while Taiwan leverages its advanced technology sector to maintain competitive advantage despite geopolitical uncertainties. The parent market is experiencing robust growth driven by rising healthcare demands and regulatory advancements. By 2035, the market is expected to evolve towards greater sustainability and digital integration, with Asia-Pacific playing a pivotal role. Middle East conflicts continue to pose risks to global supply chains, potentially affecting energy prices and raw material costs, thereby influencing production and logistics strategies in the pharmaceutical packaging sector.

Key Trends and Drivers:

The pharmaceutical packaging market is experiencing dynamic growth, driven by several key trends and drivers. One prominent trend is the increasing demand for sustainable and eco-friendly packaging solutions. As environmental concerns escalate, pharmaceutical companies are prioritizing biodegradable and recyclable materials to reduce their carbon footprint. This shift is further supported by stringent regulatory requirements and consumer preferences for greener alternatives. Technological advancements are another significant trend, with smart packaging solutions gaining traction. The integration of QR codes, RFID tags, and NFC technology enhances supply chain transparency and ensures product authenticity. These innovations not only improve patient safety but also streamline inventory management. The growing prevalence of chronic diseases and an aging population are crucial drivers for the market. This demographic shift necessitates increased production of pharmaceuticals, thereby boosting demand for packaging solutions that ensure drug stability and safety. Additionally, the rise of personalized medicine and biologics is encouraging the development of specialized packaging solutions tailored to specific drug formulations. Emerging markets present lucrative opportunities as healthcare infrastructure expands and access to medicines improves. Companies investing in these regions are poised to capture significant market share. Furthermore, the trend towards home healthcare and self-administration of medications is driving demand for user-friendly packaging designs that enhance patient adherence and convenience. As the pharmaceutical packaging market continues to evolve, companies focusing on innovation and sustainability are well-positioned for future growth.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Material Type
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by Component
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Functionality
• 2.9 Key Market Highlights by Process
• 2.10 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Blister Packaging
  • 4.1.2 Strip Packaging
  • 4.1.3 Vials
  • 4.1.4 Ampoules
  • 4.1.5 Bottles
  • 4.1.6 Sachets
  • 4.1.7 Cartridges
  • 4.1.8 Tubes
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Primary Packaging
  • 4.2.2 Secondary Packaging
  • 4.2.3 Tertiary Packaging
• 4.3 Market Size & Forecast by Material Type (2020-2035)
  • 4.3.1 Glass
  • 4.3.2 Plastic
  • 4.3.3 Metal
  • 4.3.4 Paper & Paperboard
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Active Packaging
  • 4.4.2 Intelligent Packaging
  • 4.4.3 Modified Atmosphere Packaging
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Oral Drugs
  • 4.5.2 Injectable
  • 4.5.3 Topical
  • 4.5.4 Pulmonary
  • 4.5.5 Transdermal
  • 4.5.6 Nasal
  • 4.5.7 Ocular
  • 4.5.8 IV Drugs
• 4.6 Market Size & Forecast by Component (2020-2035)
  • 4.6.1 Caps & Closures
  • 4.6.2 Labels & Accessories
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Pharmaceutical Companies
  • 4.7.2 Contract Packaging
  • 4.7.3 Retail Pharmacy
  • 4.7.4 Hospital Pharmacy
• 4.8 Market Size & Forecast by Functionality (2020-2035)
  • 4.8.1 Tamper-Evident
  • 4.8.2 Child-Resistant
  • 4.8.3 Senior-Friendly
• 4.9 Market Size & Forecast by Process (2020-2035)
  • 4.9.1 Blow-Fill-Seal
  • 4.9.2 Aseptic Filling
• 4.10 Market Size & Forecast by Solutions (2020-2035)
  • 4.10.1 Sustainable Packaging
  • 4.10.2 Smart Packaging

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Material Type
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 Component
    • 5.2.1.7 End User
    • 5.2.1.8 Functionality
    • 5.2.1.9 Process
    • 5.2.1.10 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Material Type
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 Component
    • 5.2.2.7 End User
    • 5.2.2.8 Functionality
    • 5.2.2.9 Process
    • 5.2.2.10 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Material Type
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 Component
    • 5.2.3.7 End User
    • 5.2.3.8 Functionality
    • 5.2.3.9 Process
    • 5.2.3.10 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Material Type
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 Component
    • 5.3.1.7 End User
    • 5.3.1.8 Functionality
    • 5.3.1.9 Process
    • 5.3.1.10 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Material Type
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 Component
    • 5.3.2.7 End User
    • 5.3.2.8 Functionality
    • 5.3.2.9 Process
    • 5.3.2.10 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Material Type
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 Component
    • 5.3.3.7 End User
    • 5.3.3.8 Functionality
    • 5.3.3.9 Process
    • 5.3.3.10 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Material Type
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 Component
    • 5.4.1.7 End User
    • 5.4.1.8 Functionality
    • 5.4.1.9 Process
    • 5.4.1.10 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Material Type
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 Component
    • 5.4.2.7 End User
    • 5.4.2.8 Functionality
    • 5.4.2.9 Process
    • 5.4.2.10 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Material Type
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 Component
    • 5.4.3.7 End User
    • 5.4.3.8 Functionality
    • 5.4.3.9 Process
    • 5.4.3.10 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Material Type
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 Component
    • 5.4.4.7 End User
    • 5.4.4.8 Functionality
    • 5.4.4.9 Process
    • 5.4.4.10 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Material Type
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 Component
    • 5.4.5.7 End User
    • 5.4.5.8 Functionality
    • 5.4.5.9 Process
    • 5.4.5.10 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Material Type
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 Component
    • 5.4.6.7 End User
    • 5.4.6.8 Functionality
    • 5.4.6.9 Process
    • 5.4.6.10 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Material Type
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 Component
    • 5.4.7.7 End User
    • 5.4.7.8 Functionality
    • 5.4.7.9 Process
    • 5.4.7.10 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Material Type
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 Component
    • 5.5.1.7 End User
    • 5.5.1.8 Functionality
    • 5.5.1.9 Process
    • 5.5.1.10 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Material Type
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 Component
    • 5.5.2.7 End User
    • 5.5.2.8 Functionality
    • 5.5.2.9 Process
    • 5.5.2.10 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Material Type
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 Component
    • 5.5.3.7 End User
    • 5.5.3.8 Functionality
    • 5.5.3.9 Process
    • 5.5.3.10 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Material Type
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 Component
    • 5.5.4.7 End User
    • 5.5.4.8 Functionality
    • 5.5.4.9 Process
    • 5.5.4.10 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Material Type
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 Component
    • 5.5.5.7 End User
    • 5.5.5.8 Functionality
    • 5.5.5.9 Process
    • 5.5.5.10 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Material Type
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 Component
    • 5.5.6.7 End User
    • 5.5.6.8 Functionality
    • 5.5.6.9 Process
    • 5.5.6.10 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Material Type
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 Component
    • 5.6.1.7 End User
    • 5.6.1.8 Functionality
    • 5.6.1.9 Process
    • 5.6.1.10 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Material Type
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 Component
    • 5.6.2.7 End User
    • 5.6.2.8 Functionality
    • 5.6.2.9 Process
    • 5.6.2.10 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Material Type
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 Component
    • 5.6.3.7 End User
    • 5.6.3.8 Functionality
    • 5.6.3.9 Process
    • 5.6.3.10 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Material Type
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 Component
    • 5.6.4.7 End User
    • 5.6.4.8 Functionality
    • 5.6.4.9 Process
    • 5.6.4.10 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Material Type
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 Component
    • 5.6.5.7 End User
    • 5.6.5.8 Functionality
    • 5.6.5.9 Process
    • 5.6.5.10 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Gerresheimer
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 West Pharmaceutical Services
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Amcor
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Berry Global
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Schott
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Aptar Group
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 SGD Pharma
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Nipro
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Stevanato Group
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Catalent
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Vetter Pharma
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Datwyler
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Ompi
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 West Rock
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 CCL Industries
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Ardagh Group
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Gerresheimer Bunde
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Bormioli Pharma
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Nemera
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Klockner Pentaplast
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us